November 20, 2024

Analysis Identifies New Genetic Loci for Atopic Dermatitis

Conexiant

November 20, 2024

Topical Ruxolitinib Offers Rapid Relief for Atopic Dermatitis

Conexiant

November 19, 2024

Does Tetracycline Use in Pregnancy Affect Birth Defects?

Conexiant

November 18, 2024

Renowned Dermatologist Goldsmith Dies at 86

"No one ever trades in a Rolls Royce—they just maintain the one they have," quipped pioneering dermatologist Lowell Goldsmith after cardiac surgery, exemplifying the wit and wisdom that marked his 57-year career advancing dermatologic medicine.

Conexiant

November 15, 2024

Global Study Finds Pruritus Affects 40% of Adults Worldwide

Patients with skin conditions are three times more likely to experience pruritus, highlighting a critical link between dermatologic health and quality of life.

Conexiant

November 11, 2024

Still's Disease: New EULAR/PReS Recommendations

Idiopathic arthritis and adult-onset Still’s disease now recognized as one condition.

Conexiant

November 05, 2024

CDC Warns of Hard-to-Treat U.S. Ringworm

Highly contagious and hard-to-treat fungal infections, including sexually transmitted ringworm, emerging in the U.S.

Conexiant

November 04, 2024

FDA Approves New Drug for Rosacea

FDA approves Emrosi, a new drug for rosacea treatment, to be available in 2025.

Reuters

November 04, 2024

Upadacitinib Study Shows Sustained Atopic Dermatitis Results

New data from three Phase 3 trials show upadacitinib maintains strong efficacy and safety in adolescent atopic dermatitis, with significant improvements in pruritus and skin clearance.

Conexiant